Myelodysplastic Syndromes

Quality of Life, Caregiver Impact Key to Future Imetelstat Research in Lower-Risk MDS: María Díez Campelo, MD, PhD

Imetelstat Linked to Sustained Health-Related Quality-of-Life Benefits in Lower-Risk MDS: María Díez Campelo, MD, PhD

Evaluating Imetelstat's Impact on Health-Related Quality of Life in Lower-Risk MDS: María Díez Campelo, MD, PhD

Orca-T Shows Efficacy, Reduced GVHD Risk in Acute Leukemia, MDS: Caspian Oliai, MD

Treosulfan Approval Offers Novel Option for Allo-HSCT Conditioning in AML/MDS

Treosulfan Shown Effective, Safe as Conditioning for Allo-HSCT in AML/MDS

Dr Jennifer Vaughn: We Can Provide Aggressive, Effective Treatment, but Help Patients Maintain Quality of Life

Treatment Patterns in the Management of MDS

Treatment Paradigm in Lower-Risk MDS (LR-MDS) Patients

TP53 Mutation and Its Impact on Patient Outcomes in MDS